These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
46. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386 [TBL] [Abstract][Full Text] [Related]
47. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658 [TBL] [Abstract][Full Text] [Related]
48. Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Young SG; Bihain B; Flynn LM; Sanan DA; Ayrault-Jarrier M; Jacotot B Hum Mol Genet; 1994 May; 3(5):741-4. PubMed ID: 8081360 [TBL] [Abstract][Full Text] [Related]
50. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Kissebah AH; Alfarsi S; Adams PW Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376 [TBL] [Abstract][Full Text] [Related]
51. Influence of obesity on the metabolism of apolipoprotein B in humans. Egusa G; Beltz WF; Grundy SM; Howard BV J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064 [TBL] [Abstract][Full Text] [Related]
52. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia. Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264 [TBL] [Abstract][Full Text] [Related]
54. Mutation in apolipoprotein B associated with hypobetalipoproteinemia despite decreased binding to the low density lipoprotein receptor. Benn M; Nordestgaard BG; Jensen JS; Nilausen K; Meinertz H; Tybjaerg-Hansen A J Biol Chem; 2005 Jun; 280(22):21052-60. PubMed ID: 15797858 [TBL] [Abstract][Full Text] [Related]
55. Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease). Ouguerram K; Zaïr Y; Kasbi-Chadli F; Nazih H; Bligny D; Schmitz J; Aparicio T; Chétiveaux M; Magot T; Aggerbeck LP; Samson-Bouma ME; Krempf M Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1520-5. PubMed ID: 22441101 [TBL] [Abstract][Full Text] [Related]
56. A gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B gene. Kim E; Ambroziak P; Véniant MM; Hamilton RL; Young SG J Biol Chem; 1998 Dec; 273(51):33977-84. PubMed ID: 9852051 [TBL] [Abstract][Full Text] [Related]
57. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. Ginsberg HN; Le NA; Gibson JC J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021 [TBL] [Abstract][Full Text] [Related]
59. Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred. Leppert M; Breslow JL; Wu L; Hasstedt S; O'Connell P; Lathrop M; Williams RR; White R; Lalouel JM J Clin Invest; 1988 Sep; 82(3):847-51. PubMed ID: 2901434 [TBL] [Abstract][Full Text] [Related]